Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuting Zhang

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Plos Medicine|July 5, 2022
Evaluation of a multicomponent intervention to shorten thrombolytic door-to-needle time in stroke patients in China (MISSION): A cluster-randomized controlled trialWansi Zhong, Longting Lin, Xiaoxian Gong, et al.
Nature Biotechnology|October 24, 2025
Democratizing protein language model training, sharing and collaborationJin Su, Zhikai Li, Tianli Tao, et al.
JAMA Network Open|May 6, 2022
Evaluation of a Multilevel Program to Improve Clinician Adherence to Management Guidelines for Acute Ischemic StrokeYi Chen, Xiaoxian Gong, Wansi Zhong, et al.
The New England Journal of Medicine|April 2, 2025
Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 HoursShenqiang Yan, Ying Zhou, Maarten G Lansberg, et al.
JAMA|August 7, 2025
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours: The HOPE Randomized Clinical TrialYing Zhou, Yaode He, Bruce C V Campbell, et al.
JAMA Neurology|January 8, 2024
Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration: A Randomized Clinical TrialXuting Zhang, Wansi Zhong, Rui Xue, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Plos Medicine|July 5, 2022
Evaluation of a multicomponent intervention to shorten thrombolytic door-to-needle time in stroke patients in China (MISSION): A cluster-randomized controlled trialWansi Zhong, Longting Lin, Xiaoxian Gong, et al.
Nature Biotechnology|October 24, 2025
Democratizing protein language model training, sharing and collaborationJin Su, Zhikai Li, Tianli Tao, et al.
JAMA Network Open|May 6, 2022
Evaluation of a Multilevel Program to Improve Clinician Adherence to Management Guidelines for Acute Ischemic StrokeYi Chen, Xiaoxian Gong, Wansi Zhong, et al.
The New England Journal of Medicine|April 2, 2025
Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 HoursShenqiang Yan, Ying Zhou, Maarten G Lansberg, et al.
JAMA|August 7, 2025
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours: The HOPE Randomized Clinical TrialYing Zhou, Yaode He, Bruce C V Campbell, et al.
JAMA Neurology|January 8, 2024
Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration: A Randomized Clinical TrialXuting Zhang, Wansi Zhong, Rui Xue, et al.
Pageof 7